ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NVLN Novelion Therapeutics Inc

0.68
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Novelion Therapeutics Inc NASDAQ:NVLN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.68 0.63 0.6677 0 01:00:00

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of InSite Vision, Inc. -INSV

13/06/2015 2:05am

PR Newswire (US)


Novelion Therapeutics (NASDAQ:NVLN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Novelion Therapeutics Charts.

BALA CYNWYD, Pa., June 12, 2015 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of InSite Vision, Inc. ("InSite" or "the Company") (OTC -INSV-News) for possible breaches of fiduciary duty and other violations of state law in connection with the Merger of the Company with QLT, Inc. ("QLT").

Click here to learn more about the investigation http://brodsky-smith.com/951-insv-insite-vision-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, InSite shareholder will receive only 0.048 of a share of QLT stock for each share of InSite stock they own. The investigation concerns whether the Board of InSite breached their fiduciary duties to shareholders and whether QLT is underpaying for InSite. The transaction may undervalue InSite and will result in a loss for many long term holders of InSite stock. For example, InSite stock traded as high as $0.93 per share and an analyst has set a $0.70 per share price target for the stock.  

If you own shares of InSite and wish to discuss the legal ramifications of   the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, by visiting http://brodsky-smith.com/951-insv-insite-vision-inc.html, or calling toll  free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-insite-vision-inc--insv-300098606.html

SOURCE Brodsky & Smith, LLC

Copyright 2015 PR Newswire

1 Year Novelion Therapeutics Chart

1 Year Novelion Therapeutics Chart

1 Month Novelion Therapeutics Chart

1 Month Novelion Therapeutics Chart

Your Recent History

Delayed Upgrade Clock